HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

3rd Edition of Cardiology World Conference

September 14-15, 2022 | Hybrid Event

September 14 -15, 2022 | Paris, France
CWC 2021

Enhanced external counterpulsation treatment in patients with refractory angina pectoris

Nadiye Baris Eren, Speaker at Speaker for CWC Conference- Nadiye Baris Eren
Tarsus University, Turkey
Title : Enhanced external counterpulsation treatment in patients with refractory angina pectoris


Enhanced External Counterpulsation (EECP), a treatment method used in heart failure and coronary artery diseases, is an evidence-based alternative noninvasive treatment. In addition, patients show good compliance with EECP. In this treatment carried out by a professional team, a cardiologist, a trained and experienced nurse and an assistant physician are included. The EECP device used in the treatment consists of a control console, a patient treatment table, an air compressor and three sets of cuffs. The cuffs are wrapped around the lower leg, upper leg and hip areas. During the treatment, the systolic and diastolic pressure waves of the patient, who are connected to the electrocardiogram, are followed by the finger probe. The cuffs are inflated sequentially during diastole by filling with air through the microprocessor and computer in the system. Thus, it increases the blood flow to the heart and provides oxygenation of the heart muscle. During systole, the cuffs descend simultaneously, reducing the preload of the heart. This reduces the workload of the heart. EECP is the safe and probably most appropriate treatment modality, especially for patients presenting with symptomatic Coronary artery disease who are not amenable to further revascularization. As a result of the literature review, it has been revealed that EECP consistently reduces angina pectoris and extends the time until exercise-induced ischemia. In addition, it is reported that the dependence on nitroglycerin use for frequent chest pain decreased and the quality of life increased in symptomatic patients with stable angina. Patients with refractory angina pectoris experience recurrent symptoms despite receiving medical treatment. These reduce their functional capacity, which consists of psychological distress and health-related quality of life. Symptoms seen in these patients due to EECP treatment decreased, their physical capacity levels increased and their cardiac anxiety decreased. Accordingly, the physical activity levels and life satisfaction of the patients increased. The reviewed literature also reported a small number of adverse events related to EECP. Although EECP seems to be a safe and well-tolerated treatment option in patients with refractory angina, nurses need to be careful and flexible to prevent adverse events and terminate treatment early.

Key Words: angina pectoris, coronary artery disease, Enhanced External Counterpulsation, nurse, patients


Nadiye Baris Eren, has completed her bachelor of nursing in Baskent University, master's degree in Cukurova University, and PhD in Hacettepe University. In 2010- 2014 she was employed as nurse in internal medicine intensive care unit and Surgical intensive care and reanimation unit in Baskent University Hospital in Adana in Turkey. In the mean time she has completed her postgraduate (2015) and PhD (2021) on Fundamentals of Nursing. Se worked at various universities. She is currently working as assistant professor doctor at Tarsus University.